Traditional Chinese medicinal preparation for treating diabetic retinopathy

Abstract

The invention belongs to the field of traditional Chinese medicinal preparations and in particular relates to a traditional Chinese medicinal preparation for treating diabetic retinopathy. The traditional Chinese medicinal preparation is prepared from the following traditional Chinese medicinal raw materials in part by weight: 20 to 30 parts of raw astragalus, 12 to 20 parts of raw rehmannia root, 20 to 30 parts of barbary wolfberry fruit, 25 to 35 parts of yam, 20 to 30 parts of vine root, 15 to 30 parts of salvia miltiorrhiza bunge, 3 to 8 parts of pseudo-ginseng root powder, 12 to 20 parts of motherwort fruit, 6 to 15 parts of oriental waterplantain rhizome, 8 to 12 parts of bitter orange, 15 to 25 parts of kelp and 15 to 25 parts of seaweed. The medicines are used in combination to conduct the concerted functions of tonifying qi and yin, promoting the production of body fluid, quenching thirst, promoting blood circulation, removing blood stasis, promoting diuresis and eliminating phlegm to nurse eyes and treat symptoms by tonifying qi and yin, removing phlegm and stasis and promoting blood circulation. The traditional Chinese medicinal preparation, when used for treating diabetic retinopathy, has the characteristics of avoiding untoward effects, being prepared from readily available medicinal sources, along with exact treatment effect, quick effectiveness, high tolerance, low cost, convenience for administration and the like.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine preparations, in particular to a traditional Chinese medicine preparation for treating diabetic retinopathy. Background technique [0002] Diabetes mellitus (DM) is a disorder of glucose metabolism that affects various organs and blood vessels in the body, and diabetic retinopathy (DR) is one of the serious complications of diabetes. With the gradual improvement of living standards, the life expectancy of DM patients is prolonged, but the incidence of DR is increasing year by year, and has become the main blinding eye disease. The main clinical manifestations are gradually decreased visual acuity, fundus retinal changes such as hemangioma, hemorrhage, exudation, cotton-wool spots, new blood vessels, and proliferative changes. So far, the pathogenesis of DR has not been fully understood, and no breakthrough has been made in the treatment, especially in the prevention of the deterioratio...

AI Technical Summary

Problems solved by technology

For proliferative DR, local therapy such as laser photocoagulation and vitrectomy should be considered. Laser photocoagulation and vitrectomy are limited by conditions and have certain indications and complications, which are not easy for patients to accept. The curative effect is not ideal